Melatonin Treatment in Kidney Diseases

Area of Science:

• Neuroendocrinology
• Nephrology

Background:

• Melatonin, a pineal gland neurohormone, regulates circadian rhythms and impacts numerous bodily functions.
• Disruptions in sleep-wake cycles can lead to nervous system imbalance, metabolic, and endocrine issues.
• Chronic kidney disease (CKD) is linked to cardiovascular, diabetic, and homeostatic derangements, affecting quality of life.

Purpose of the Study:

• To review the potential benefits of melatonin in kidney diseases.
• To explore melatonin's indirect connections to kidney function via cardiovascular, diabetic, and homeostatic pathways.
• To highlight melatonin's role in managing CKD complications.

Main Methods:

• Literature review of existing studies on melatonin and kidney disease.
• Analysis of melatonin's antioxidant, free radical scavenging, and cytoprotective properties.
• Examination of clinical reports on melatonin's impact on renal function and CKD progression.

Main Results:

• Melatonin exhibits significant antioxidant, free radical scavenging, and cytoprotective effects.
• Supplementation is beneficial in various kidney injuries due to its anti-inflammatory and anti-apoptotic actions.
• Melatonin demonstrates a renoprotective effect, inhibiting the progression of renal failure complications.

Conclusions:

• Melatonin supplementation can be beneficial in nearly all types of kidney injury.
• Exogenous melatonin administration offers a renoprotective effect and manages CKD complications.
• Melatonin supplementation is well-tolerated with a low incidence of side effects.